CRIXIVAN®:: A potent inhibitor of HIV-1 protease in vivo

被引：0
|
作者：
Huff, JR [1 ]
Vacca, JP [1 ]
Dorsey, BD [1 ]
Emini, EA [1 ]
Condra, JH [1 ]
Schleif, WA [1 ]
Massari, FE [1 ]
Deutsch, PJ [1 ]
Chodakewitz, J [1 ]
Kuo, LC [1 ]
Chen, Z [1 ]
机构：
[1] Merck Res Labs, W Point, PA USA
来源：
FASEB JOURNAL | 1997年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A23
引用
收藏
页码：A856 / A856
页数：1
相关论文
共 50 条
  • [1] Crixivan(TM): A potent inhibitor of HIV-1 protease in vivo.
    Huff, JR
    Vacca, JR
    Dorsey, BD
    Emini, EA
    Condra, JH
    Schleif, WA
    Massari, FE
    Deutsch, PJ
    Chodakewitz, J
    Kuo, LC
    Chen, Z
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 255 - MEDI
  • [2] Aromatic P-1 replacements for the highly potent HIV-1 protease inhibitor CRIXIVAN(R)
    Coburn, CA
    Young, MB
    Hungate, RW
    Isaacs, RCA
    Vacca, JP
    Huff, JR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (16) : 1937 - 1940
  • [3] The invention and development of CRIXIVAN®:: An HIV protease inhibitor
    Dorsey, BD
    Guare, JP
    Holloway, MK
    Hungate, RW
    Vacca, JP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1197 - U1197
  • [4] Indinavir sulfate crixivan® -: Anti-HIV HIV protease inhibitor
    不详
    DRUGS OF THE FUTURE, 2000, 25 (06) : 637 - 637
  • [5] HIV-1 protease inhibitor
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (06) : 261 - 261
  • [6] A folding inhibitor of the HIV-1 protease
    Broglia, RA
    Provasi, D
    Vasile, F
    Ottolina, G
    Longhi, R
    Tiana, G
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2006, 62 (04) : 928 - 933
  • [7] Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans
    Balani, SK
    Woolf, EJ
    Hoagland, VL
    Sturgill, MG
    Deutsch, PJ
    Yeh, KC
    Lin, JH
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (12) : 1389 - 1394
  • [8] In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix
    Datir, Rawlings
    Kemp, Steven
    El Bouzidi, Kate
    Mlchocova, Petra
    Goldstein, Richard
    Breuer, Judy
    Towers, Greg J.
    Jolly, Clare
    Quinones-Mateu, Miguel E.
    Dakum, Patrick S.
    Ndembi, Nicaise
    Gupta, Ravindra K.
    MBIO, 2020, 11 (06): : 1 - 15
  • [9] Optimization of a macromolecular inhibitor of HIV-1 protease
    Dauber, DS
    McPhee, F
    Ünal, A
    Craik, CS
    ASPARTIC PROTEINASES: RETROVIRAL AND CELLULAR ENZYMES, 1998, 436 : 65 - 70
  • [10] Protease inhibitor resistance in HIV-1 infection
    Resch, W
    Swanstrom, R
    REVIEWS IN MEDICAL MICROBIOLOGY, 2000, 11 (04) : 211 - 221
12345